IRONWOOD PHARMACEUTICALS, INC. Fair Value Adjustment of Warrants
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Fair Value Adjustment of Warrants of -$19.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-03-31
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-03-31 was -$19.00K.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2023 was -$19.00K.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2022 was -$182.00K.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2021 was -$10.77M.
- IRONWOOD PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2020 was -$12.17M, a 174.99% decline from fiscal 2019.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | -$19.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | -$19.00K 10-Q · filed 2024-11-07 | $1.11M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$19.00K 10-Q · filed 2024-08-08 | $1.11M derived: sum of 3 quarters · filed 2025-03-31 | $963.00K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | -$19.00K 10-Q · filed 2024-05-09 | $1.11M derived: sum of 2 quarters · filed 2025-03-31 | $963.00K derived: sum of 3 quarters · filed 2025-03-31 | $216.00K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $982.00K derived: sum of 2 quarters · filed 2025-03-31 | $235.00K derived: sum of 3 quarters · filed 2025-03-31 | -$182.00K 10-K · filed 2025-03-31 | -$1.30M 10-K · filed 2023-02-16 |
| 2022-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$898.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.31M 10-Q · filed 2023-11-09 | -$5.49M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-06-30 | -$747.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.16M 10-Q · filed 2023-08-09 | -$5.34M derived: sum of 3 quarters · filed 2024-02-16 | -$10.91M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2022-03-31 | -$417.00K 10-Q · filed 2023-05-04 | -$4.59M derived: sum of 2 quarters · filed 2024-02-16 | -$10.16M derived: sum of 3 quarters · filed 2024-02-16 | -$7.08M derived: sum of 4 quarters · filed 2024-02-16 | |
| 2021-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$9.74M derived: sum of 2 quarters · filed 2024-02-16 | -$6.66M derived: sum of 3 quarters · filed 2024-02-16 | -$10.77M 10-K · filed 2024-02-16 | |
| 2021-09-30 | -$5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$2.49M derived: sum of 2 quarters · filed 2022-11-03 | -$6.60M 10-Q · filed 2022-11-03 | -$2.21M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.03M 10-Q · filed 2022-08-04 | $3.37M derived: sum of 3 quarters · filed 2023-02-16 | -$1.90M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | -$4.11M 10-Q · filed 2022-05-05 | $284.00K derived: sum of 2 quarters · filed 2023-02-16 | -$4.98M derived: sum of 3 quarters · filed 2023-02-16 | -$4.23M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$870.00K derived: sum of 2 quarters · filed 2023-02-16 | -$119.00K derived: sum of 3 quarters · filed 2023-02-16 | -$12.17M 10-K · filed 2023-02-16 | |
| 2020-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$4.51M derived: sum of 2 quarters · filed 2021-11-04 | -$16.57M 10-Q · filed 2021-11-04 | -$1.07M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-06-30 | $751.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$11.30M 10-Q · filed 2021-08-05 | $4.19M derived: sum of 3 quarters · filed 2022-02-18 | -$11.50M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-03-31 | -$12.05M 10-Q · filed 2021-05-06 | $3.44M derived: sum of 2 quarters · filed 2022-02-18 | -$12.25M derived: sum of 3 quarters · filed 2022-02-18 | -$1.45M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2019-12-31 | $15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$196.00K derived: sum of 2 quarters · filed 2022-02-18 | $10.61M derived: sum of 3 quarters · filed 2022-02-18 | $16.23M 10-K · filed 2022-02-18 | |
| 2019-09-30 | -$15.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.88M derived: sum of 2 quarters · filed 2020-11-05 | $740.00K 10-Q · filed 2020-11-05 | -$88.28M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-30 | $10.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $16.43M 10-Q · filed 2020-08-06 | -$72.59M derived: sum of 3 quarters · filed 2021-02-17 | -$92.83M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-31 | $5.63M 10-Q · filed 2020-05-06 | -$83.39M derived: sum of 2 quarters · filed 2021-02-17 | -$103.63M derived: sum of 3 quarters · filed 2021-02-17 | -$56.74M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-31 | -$89.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$109.26M derived: sum of 2 quarters · filed 2021-02-17 | -$62.37M derived: sum of 3 quarters · filed 2021-02-17 | -$58.42M 10-K · filed 2021-02-17 | |
| 2018-09-30 | -$20.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $26.65M derived: sum of 2 quarters · filed 2019-10-31 | $30.59M 10-Q · filed 2019-10-31 | $19.04M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-06-30 | $46.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $50.83M 10-Q · filed 2019-07-30 | $39.28M derived: sum of 3 quarters · filed 2020-02-13 | -$6.44M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-03-31 | $3.94M 10-Q · filed 2019-05-02 | -$7.61M derived: sum of 2 quarters · filed 2020-02-13 | -$53.33M derived: sum of 3 quarters · filed 2020-02-13 | -$37.30M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2017-12-31 | -$11.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$57.27M derived: sum of 2 quarters · filed 2020-02-13 | -$41.24M derived: sum of 3 quarters · filed 2020-02-13 | -$21.05M 10-K · filed 2020-02-13 | |
| 2017-09-30 | -$45.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$29.68M derived: sum of 2 quarters · filed 2018-11-06 | -$9.49M 10-Q · filed 2018-11-06 | -$16.38M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $16.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $36.22M 10-Q · filed 2018-08-06 | $29.34M derived: sum of 3 quarters · filed 2019-02-25 | $62.62M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $20.19M 10-Q · filed 2018-05-04 | $13.30M derived: sum of 2 quarters · filed 2019-02-25 | $46.59M derived: sum of 3 quarters · filed 2019-02-25 | $65.23M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $26.40M derived: sum of 2 quarters · filed 2019-02-25 | $45.04M derived: sum of 3 quarters · filed 2019-02-25 | $37.91M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $33.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $51.93M derived: sum of 2 quarters · filed 2017-11-02 | $44.79M 10-Q · filed 2017-11-02 | $57.15M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-06-30 | $18.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $11.51M 10-Q · filed 2017-08-03 | $23.86M derived: sum of 3 quarters · filed 2018-02-22 | $17.38M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-03-31 | -$7.13M 10-Q · filed 2017-05-08 | $5.22M derived: sum of 2 quarters · filed 2018-02-22 | -$1.26M derived: sum of 3 quarters · filed 2018-02-22 | ||
| 2015-12-31 | $12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $5.87M derived: sum of 2 quarters · filed 2018-02-22 | $4.48M 10-K · filed 2018-02-22 | ||
| 2015-09-30 | -$6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$7.87M 10-Q · filed 2016-11-07 | |||
| 2015-06-30 | -$1.39M 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |